Anthony Lawler CEO TRG Natural Pharmaceuticals

Anthony Lawler – CEO

Anthony brings a wealth of experience in the natural health, biotech, food and beverage industries. He has a strong track record of driving revenue growth and capital raising with leading companies such as A2 Milk, Vital Foods and more recently Good Heath Products.

Anthony has key skills in General Management, Sales, Marketing, Regulatory, Production, Supply Chain and New Product Development. He also brings a large amount of international market experience particularly in China, South Korea, Australia, USA, Hong Kong, Vietnam, Indonesia.

Dr Shaun Hault - TRG Natural Pharmaceuticals

Dr Shaun Holt – Founder, Chief Scientific Officer & Director.

Dr Shaun Holt holds Pharmacy and Medicine degrees. He has been the Principal Investigator in over 50 clinical trials and has over 230 publications in medical literature.

Shaun has been a regular contributor on TV1’s Breakfast programme and often appears on national radio shows. He is the author of 10 books including the bestseller, Natural Remedies That Really Work, was a finalist in the 2015 New Zealander of the Year Awards in the Innovator category, and was a finalist in the 2019 New Zealand Entrepreneur of the Year Awards.

Kobie Hetet – Supply Chain Manager

Kobie has over 20 years of experience in supply chain, mainly working in procurement and inventory management within a fast moving consumer goods manufacturing environment.

Having worked for one of New Zealand’s leading manufacturers and exporters for the last 17 years, Kobie has gained a wealth of knowledge across the whole supply chain.

Kobie is passionate about all-natural health and natural skincare products.

Ian Boddy | TRG Natural Pharmaceuticals

Dr Ian Boddy – Chair

Dr Ian Boddy, who has a PhD in organic chemistry, was a Research Fellow at Cambridge University and a Senior Research Leader with the large German agrochemicals company, Schering AG.

He is also well-known for his time with the New Zealand Crown Research Institute AgResearch as GM Commercial.

Brendon Barnes Director | TRG Natural Pharmaceuticals

Brendon Barnes – Director

Brendon is the Chief Investment Officer for Quayside Holdings. Brendon comes from an investment banking background and spent 11 years working overseas with the Macquarie Group and the Abu Dhabi Investment Authority.

He holds a BCA (Accounting and Commercial Law) and a Graduate Diploma (Professional Accounting) from Victoria University. Brendon is a member of the Institute of Directors.